Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Virol ; 85(1): 315-23, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-20962088

RESUMEN

The innate immune pathways that contribute to the potent immunogenicity of recombinant adenovirus (rAd) vaccine vectors remain largely undefined. Previous studies assessing innate immunity triggered by vaccine vectors have largely focused on in vitro studies involving antigen-presenting cells and on early in vivo inflammatory responses. Here, we systematically explore the Toll-like receptor (TLR) signaling requirements for the generation of cellular immune responses by intramuscular immunization with common and alternative serotype rAd vectors in mice. Antigen-specific CD8(+) T-lymphocyte responses elicited by these rAd vectors were significantly diminished in MyD88(-/-) mice but not in TRIF(-/-) or TLR3(-/-) mice, suggesting the importance of MyD88-dependent TLR signaling. However, the absence of each individual TLR resulted in minimal to no effect on vaccine-elicited cellular immune responses. Moreover, responses were not diminished in IL-1R(-/-) or IL-18R(-/-) mice. These data suggest that rAd vectors engage multiple MyD88-dependent signaling pathways, none of which are individually critical; rather, they are integrated to contribute to the potent immunogenicity of rAd vectors. Stimulation of multiple innate immune mechanisms may prove a generalizable property of potent vaccines, and this strategy could be harnessed in the development of next-generation vaccine vectors and adjuvants.


Asunto(s)
Adenoviridae/inmunología , Vectores Genéticos/inmunología , Inmunidad Innata , Vacunas Sintéticas/inmunología , Vacunas Virales/inmunología , Adenoviridae/clasificación , Adenoviridae/genética , Animales , Linfocitos T CD8-positivos/inmunología , Vectores Genéticos/administración & dosificación , Inmunización , Ratones , Ratones Endogámicos C57BL , Factor 88 de Diferenciación Mieloide/genética , Factor 88 de Diferenciación Mieloide/metabolismo , Serotipificación , Transducción de Señal , Receptores Toll-Like/metabolismo , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Virales/administración & dosificación , Vacunas Virales/genética
2.
J Virol ; 84(19): 10413-9, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20631129

RESUMEN

Toll-like receptor (TLR) ligands are critical activators of innate immunity and are being developed as vaccine adjuvants. However, their utility in conjunction with viral vector-based vaccines remains unclear. In this study, we evaluated the impact of a variety of TLR ligands on antigen-specific CD8(+) T lymphocyte responses elicited by a recombinant adenovirus serotype 26 (rAd26) vector expressing simian immunodeficiency virus Gag in mice. The TLR3 ligand poly(I:C) suppressed Gag-specific cellular immune responses, whereas the TLR4 ligands lipopolysaccharide and monophosphoryl lipid A substantially augmented the magnitude and functionality of these responses by a MyD88- and TRIF-dependent mechanism. These data demonstrate that TLR ligands can modulate the immunogenicity of viral vaccine vectors both positively and negatively. Moreover, these findings suggest the potential utility of TLR4 ligands as adjuvants for rAd vector-based vaccines.


Asunto(s)
Linfocitos T CD8-positivos/inmunología , Vectores Genéticos , Receptor Toll-Like 4/metabolismo , Vacunas Virales/genética , Vacunas Virales/inmunología , Adenoviridae/genética , Adyuvantes Inmunológicos/administración & dosificación , Animales , Genes gag , Ligandos , Lipopolisacáridos/administración & dosificación , Ratones , Ratones Endogámicos C57BL , Poli I-C/administración & dosificación , Virus de la Inmunodeficiencia de los Simios/genética , Vacunas Sintéticas/administración & dosificación , Vacunas Sintéticas/genética , Vacunas Sintéticas/inmunología , Vacunas Virales/administración & dosificación
3.
BJR Open ; 1(1): 20180044, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-33178929

RESUMEN

Management of prostate cancer relies heavily on accurate risk stratification obtained through biopsies, which are conventionally performed under transrectal ultrasound (TRUS) guidance. Yet, multiparametric MRI has grown to become an integral part of the care of males with known or suspected prostate cancer. This article will discuss in detail the different MRI-targeted biopsy techniques, their advantages and disadvantages, and the impact they have on patient management.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA